Company Overview

Key Facts

Employs 100 scientists, about half chemists and half biologists. Spent $96 million on R&D in 2005.

Key Financial Facts

2005 revenue: $7.8 million 1-yr. growth rate: –44.5 percent

Personnel Highlights

Number of employees: 177 1-yr. growth rate: –4.8 percent

Company Overview

Incyte made a name for itself in the field of bioinformatics, a virtual laboratory in which scientists use computers to retrieve, process, and analyze biological information. But when bioinformatics didn't produce the tsunami of discovery (and revenue) that scientists (and investors) were anticipating, Incyte changed directions to focus more on drug discovery and development, in addition to licensing its biological data to other companies. It focuses on drugs for cancer, inflammation, HIV, and diabetes. It’s working in partnership with Pfizer on CCR2 antagonists, which are promising treatments for inflammatory diseases.